Free Trial

IceCure Medical (ICCM) Competitors

IceCure Medical logo
$1.16 -0.10 (-7.94%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$1.20 +0.05 (+3.88%)
As of 04:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICCM vs. ZIMV, SNWV, PDEX, NVRO, LUNG, NYXH, RCEL, CVRX, ELMD, and INGN

Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include ZimVie (ZIMV), SANUWAVE Health (SNWV), Pro-Dex (PDEX), Nevro (NVRO), Pulmonx (LUNG), Nyxoah (NYXH), AVITA Medical (RCEL), CVRx (CVRX), Electromed (ELMD), and Inogen (INGN). These companies are all part of the "medical equipment" industry.

IceCure Medical vs.

IceCure Medical (NASDAQ:ICCM) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and analyst recommendations.

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 95.6% of ZimVie shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 3.0% of ZimVie shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

IceCure Medical currently has a consensus target price of $2.50, suggesting a potential upside of 115.52%. ZimVie has a consensus target price of $19.50, suggesting a potential upside of 115.71%. Given ZimVie's higher probable upside, analysts plainly believe ZimVie is more favorable than IceCure Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
ZimVie
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
3.00

IceCure Medical received 20 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 96.30% of users gave IceCure Medical an outperform vote while only 28.57% of users gave ZimVie an outperform vote.

CompanyUnderperformOutperform
IceCure MedicalOutperform Votes
26
96.30%
Underperform Votes
1
3.70%
ZimVieOutperform Votes
6
28.57%
Underperform Votes
15
71.43%

ZimVie has a net margin of -77.31% compared to IceCure Medical's net margin of -376.85%. ZimVie's return on equity of 2.90% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-376.85% -124.44% -87.70%
ZimVie -77.31%2.90%1.17%

IceCure Medical has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500.

In the previous week, IceCure Medical had 2 more articles in the media than ZimVie. MarketBeat recorded 4 mentions for IceCure Medical and 2 mentions for ZimVie. ZimVie's average media sentiment score of 1.20 beat IceCure Medical's score of 0.58 indicating that ZimVie is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IceCure Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
ZimVie
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

IceCure Medical has higher earnings, but lower revenue than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.29M19.56-$14.65M-$0.30-3.87
ZimVie$449.75M0.56-$393.28M-$0.95-9.52

Summary

ZimVie beats IceCure Medical on 10 of the 18 factors compared between the two stocks.

Get IceCure Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICCM vs. The Competition

MetricIceCure MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$64.38M$4.33B$5.53B$7.93B
Dividend YieldN/A39.93%5.11%4.22%
P/E Ratio-4.0030.0322.5118.54
Price / Sales19.5655.31397.62103.30
Price / CashN/A51.0838.1834.62
Price / Book4.306.056.734.25
Net Income-$14.65M$68.71M$3.22B$248.18M
7 Day Performance-3.33%-0.24%1.38%1.03%
1 Month Performance-6.45%-2.90%2.79%2.70%
1 Year Performance-1.69%21.00%15.41%4.05%

IceCure Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICCM
IceCure Medical
2.7159 of 5 stars
$1.16
-7.9%
$2.50
+115.5%
-0.9%$64.38M$3.29M-4.0060Short Interest ↓
Gap Up
ZIMV
ZimVie
2.4826 of 5 stars
$9.31
-1.4%
$19.50
+109.5%
-41.7%$259.26M$449.75M-0.712,700Positive News
SNWV
SANUWAVE Health
N/A$27.40
-3.8%
N/AN/A$234.24M$32.63M-7.0340High Trading Volume
PDEX
Pro-Dex
1.4251 of 5 stars
$69.00
+6.3%
$52.00
-24.6%
+261.6%$225.01M$61.00M34.33140Short Interest ↑
News Coverage
Positive News
High Trading Volume
NVRO
Nevro
0.1892 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-43.8%$224.32M$408.52M-3.091,090Upcoming Earnings
Analyst Forecast
LUNG
Pulmonx
3.731 of 5 stars
$5.19
-0.2%
$12.75
+145.7%
-51.2%$208.88M$83.79M-3.60250Earnings Report
Upcoming Earnings
Analyst Forecast
News Coverage
Gap Up
NYXH
Nyxoah
2.2831 of 5 stars
$6.01
+2.4%
$14.50
+141.3%
-36.6%$204.70M$4.52M-3.21110
RCEL
AVITA Medical
1.6879 of 5 stars
$10.25
+1.8%
$17.25
+68.3%
+8.0%$198.26M$64.25M-4.29130News Coverage
Gap Down
CVRX
CVRx
3.1145 of 5 stars
$7.52
+11.7%
$16.83
+123.8%
-28.0%$195.79M$51.29M-2.80160Upcoming Earnings
Short Interest ↓
News Coverage
Positive News
High Trading Volume
ELMD
Electromed
0.6146 of 5 stars
$22.87
-0.8%
$38.00
+66.2%
+30.6%$195.70M$59.63M30.49160Analyst Upgrade
Positive News
INGN
Inogen
2.5599 of 5 stars
$7.27
-0.1%
$7.00
-3.7%
+0.1%$195.47M$335.71M-3.231,030Upcoming Earnings
Short Interest ↑
Positive News

Related Companies and Tools


This page (NASDAQ:ICCM) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners